| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Loewald
CEO | Chief Executive Officer | 63 | 06/09/2020 |
Robert Green
DFI | Director of Finance/CFO | 54 | 31/12/2019 |
Matthew Bio
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Wayne Hewett
CHM | Chairman | 61 | 30/11/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.08% | - | - | 2.02B | ||
| +0.43% | +4.31% | +90.84% | +130.99% | 1,088B | ||
| +0.41% | +1.27% | +50.98% | +50.05% | 629B | ||
| -0.53% | +1.04% | +25.23% | +63.46% | 440B | ||
| -0.33% | -0.11% | +45.90% | +37.55% | 359B | ||
| -0.27% | -0.94% | +27.15% | +36.38% | 291B | ||
| -0.45% | -1.66% | +1.83% | +4.85% | 245B | ||
| +0.45% | +2.05% | +46.04% | +58.54% | 225B | ||
| -0.78% | +1.36% | -8.68% | -51.95% | 204B | ||
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | ||
| Average | -0.13% | +1.27% | +32.50% | +44.41% | 405.47B | |
| Weighted average by Cap. | +0.02% | +1.93% | +48.67% | +66.16% |
Employees
-
Sector
Pharmaceuticals
















